Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence

M Treskova-Schwarzbach, L Haas, S Reda, A Pilic… - BMC medicine, 2021 - Springer
Background This study applies an umbrella review approach to summarise the global
evidence on the risk of severe COVID-19 outcomes in patients with pre-existing health …

Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study

P Aveyard, M Gao, N Lindson… - The lancet Respiratory …, 2021 - thelancet.com
Background Previous studies suggested that the prevalence of chronic respiratory disease
in patients hospitalised with COVID-19 was lower than its prevalence in the general …

Post–COVID-19 syndrome (long haul syndrome): description of a multidisciplinary clinic at Mayo clinic and characteristics of the initial patient cohort

G Vanichkachorn, R Newcomb, CT Cowl… - Mayo clinic …, 2021 - Elsevier
Objective To describe characteristics of a series of patients reporting prolonged symptoms
after an infection with coronavirus disease 2019 (COVID-19). Patients and Methods This …

[HTML][HTML] Long noncoding RNA XIST: mechanisms for X chromosome inactivation, roles in sex-biased diseases, and therapeutic opportunities

J Li, Z Ming, L Yang, T Wang, G Liu, Q Ma - Genes & Diseases, 2022 - Elsevier
Sexual dimorphism has been reported in various human diseases including autoimmune
diseases, neurological diseases, pulmonary arterial hypertension, and some types of …

COVID-19 in cancer patients: clinical characteristics and outcome—an analysis of the LEOSS registry

MM Rüthrich, C Giessen-Jung, S Borgmann… - Annals of …, 2021 - Springer
Introduction Since the early SARS-CoV-2 pandemic, cancer patients have been assumed to
be at higher risk for severe COVID-19. Here, we present an analysis of cancer patients from …

Risks of digestive diseases in long COVID: evidence from a population-based cohort study

Y Ma, L Zhang, R Wei, W Dai, R Zeng, D Luo, R Jiang… - BMC medicine, 2024 - Springer
Background In the post-pandemic era, a wide range of COVID-19 sequelae is of growing
health concern. However, the risks of digestive diseases in long COVID have not been …

Post-COVID-19 syndrome: retinal microcirculation as a potential marker for chronic fatigue

S Schlick, M Lucio, G Wallukat, A Bartsch… - International Journal of …, 2022 - mdpi.com
Post-COVID-19 syndrome (PCS) is characterized by persisting sequelae after infection with
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). PCS can affect patients …

In-hospital mortality and morbidity in cancer patients with COVID-19: a nationwide analysis from the United States

Z Abuhelwa, A Alsughayer, AY Abuhelwa, A Beran… - Cancers, 2022 - mdpi.com
Simple Summary Patients with cancer are considered a vulnerable population and might
have an increased risk for severe outcomes of coronavirus disease 2019 (COVID-19). We …

High number and specific comorbidities could impact the immune response in COVID-19 patients

D Liu, X Yuan, F Gao, B Zhao, L Ding, M Huan… - Frontiers in …, 2022 - frontiersin.org
Background Cellular immunodeficiency and comorbidities are common in COVID-19
patients. Aim The purpose of this study was to investigate comorbidities impacting on the …

Cancer patients with COVID-19: a retrospective study of 51 patients in the district of Piacenza, Northern Italy

L Cavanna, C Citterio, I Toscani, C Franco… - Future Science …, 2021 - Taylor & Francis
Background: Cancer patients are considered a highly fragile group in the current
coronavirus disease 2019 (COVID-19) pandemic. Material & methods: In this study, patients …